DUBLIN--(BUSINESS WIRE)--Dec. 17, 2018-- Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the 37^th Annual J.P. Morgan Healthcare Conference. Timothy P. Walbert, chairman, president and chief executive officer, will present at 4:30 p.m. PT on Jan. 8, 2019.

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter or like us on Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181217005196/en/

Source: Horizon Pharma plc

Investors:
Tina Ventura
Senior Vice President
Investor Relations
investor-relations@horizonpharma.com

Ruth Venning
Executive Director
Investor Relations
investor-relations@horizonpharma.com

U.S. Media:
Geoff Curtis
Executive Vice President
Corporate Affairs & Chief Communications Officer
media@horizonpharma.com

Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie